Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Arthritis Research & Therapy

Figure 1

From: Myeloid dendritic cells correlate with clinical response whereas plasmacytoid dendritic cells impact autoantibody development in rheumatoid arthritis patients treated with infliximab

Figure 1

Circulating dendritic cell subset levels in patients with active rheumatoid arthritis and in healthy volunteers. Dendritic cell (DC) subsets were measured in the peripheral blood of patients with rheumatoid arthritis (RA) (n = 61) and in healthy subjects (n = 30). The mean numbers per milliliter of blood of CD11c+CD123-Lin-HLA-DR+ myeloid dendritic cells (mDCs) and CD11c-CD123+Lin-HLA-DR+ plasmacytoid dendritic cells (pDCs) are shown (mean ± standard deviation). *P < 0.0001 and **P < 0.001, Mann–Whitney U test.

Back to article page